JP2024515064A5 - - Google Patents
Info
- Publication number
- JP2024515064A5 JP2024515064A5 JP2023561909A JP2023561909A JP2024515064A5 JP 2024515064 A5 JP2024515064 A5 JP 2024515064A5 JP 2023561909 A JP2023561909 A JP 2023561909A JP 2023561909 A JP2023561909 A JP 2023561909A JP 2024515064 A5 JP2024515064 A5 JP 2024515064A5
- Authority
- JP
- Japan
- Prior art keywords
- cells
- feeder
- derived
- feeder cells
- composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB2105113.1 | 2021-04-09 | ||
| GBGB2105113.1A GB202105113D0 (en) | 2021-04-09 | 2021-04-09 | Novel method |
| PCT/GB2022/050886 WO2022214825A1 (en) | 2021-04-09 | 2022-04-08 | Novel method |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024515064A JP2024515064A (ja) | 2024-04-04 |
| JP2024515064A5 true JP2024515064A5 (https=) | 2025-04-16 |
Family
ID=75949435
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023561909A Pending JP2024515064A (ja) | 2021-04-09 | 2022-04-08 | 新規方法 |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US20240197875A1 (https=) |
| EP (1) | EP4320225A1 (https=) |
| JP (1) | JP2024515064A (https=) |
| KR (1) | KR20230167047A (https=) |
| CN (1) | CN117222732A (https=) |
| AR (1) | AR125325A1 (https=) |
| AU (1) | AU2022254859A1 (https=) |
| BR (1) | BR112023020584A2 (https=) |
| CA (1) | CA3216225A1 (https=) |
| CO (1) | CO2023015121A2 (https=) |
| GB (1) | GB202105113D0 (https=) |
| IL (1) | IL307395A (https=) |
| MX (1) | MX2023011975A (https=) |
| TW (1) | TW202305120A (https=) |
| WO (1) | WO2022214825A1 (https=) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN121532496A (zh) * | 2023-07-20 | 2026-02-13 | 武田药品工业株式会社 | 用于制备γδT细胞的无网格方法 |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6028176A (en) | 1996-07-19 | 2000-02-22 | Bayer Corporation | High-affinity interleukin-4 muteins |
| EP1777294A1 (en) | 2005-10-20 | 2007-04-25 | Institut National De La Sante Et De La Recherche Medicale (Inserm) | IL-15Ralpha sushi domain as a selective and potent enhancer of IL-15 action through IL-15Rbeta/gamma, and hyperagonist (IL15Ralpha sushi -IL15) fusion proteins |
| WO2007111714A2 (en) | 2005-11-28 | 2007-10-04 | Zymogenetics, Inc. | Il-21 antagonists |
| CA2860170C (en) | 2010-12-22 | 2022-06-14 | The Board Of Trustees Of The Leland Stanford Junior University | Superagonists and antagonists of interleukin-2 |
| RU2739770C2 (ru) | 2014-06-11 | 2020-12-28 | полибайосепт ГмбХ | Экспансия лимфоцитов с использованием композиции цитокинов для активной клеточной иммунотерапии |
| IL297773B2 (en) * | 2014-11-17 | 2024-07-01 | Adicet Bio Inc | Engineered gamma delta t-cells |
| WO2017072367A1 (en) | 2015-10-30 | 2017-05-04 | Cancer Research Technology Limited | EXPANSION OF NON-HAEMATOPOIETIC TISSUE-RESIDENT γδ T CELLS AND USES OF THESE CELLS |
| KR20190098747A (ko) * | 2016-12-05 | 2019-08-22 | 주노 쎄러퓨티크스 인코퍼레이티드 | 입양 세포 치료법을 위한 조작된 세포의 제조방법 |
| GB201707048D0 (en) * | 2017-05-03 | 2017-06-14 | King S College London | Expansion of gamma delta cells, compositions, and methods of use thereof |
| CA3106056A1 (en) * | 2018-07-26 | 2020-01-30 | Ospedale Pediatrico Bambino Gesu (Opbg) | Therapeutic preparations of gamma-delta t cells and natural killer cells and methods for manufacture and use |
| CN113423820A (zh) | 2018-11-08 | 2021-09-21 | 伽马三角洲疗法有限公司 | 分离和扩增细胞的方法 |
| GB201818243D0 (en) | 2018-11-08 | 2018-12-26 | Gammadelta Therapeutics Ltd | Methods for isolating and expanding cells |
-
2021
- 2021-04-09 GB GBGB2105113.1A patent/GB202105113D0/en not_active Ceased
-
2022
- 2022-04-07 TW TW111113146A patent/TW202305120A/zh unknown
- 2022-04-08 AR ARP220100901A patent/AR125325A1/es unknown
- 2022-04-08 IL IL307395A patent/IL307395A/en unknown
- 2022-04-08 WO PCT/GB2022/050886 patent/WO2022214825A1/en not_active Ceased
- 2022-04-08 EP EP22718260.7A patent/EP4320225A1/en active Pending
- 2022-04-08 KR KR1020237035356A patent/KR20230167047A/ko active Pending
- 2022-04-08 CA CA3216225A patent/CA3216225A1/en active Pending
- 2022-04-08 MX MX2023011975A patent/MX2023011975A/es unknown
- 2022-04-08 AU AU2022254859A patent/AU2022254859A1/en active Pending
- 2022-04-08 CN CN202280027447.0A patent/CN117222732A/zh active Pending
- 2022-04-08 JP JP2023561909A patent/JP2024515064A/ja active Pending
- 2022-04-08 US US18/554,501 patent/US20240197875A1/en active Pending
- 2022-04-08 BR BR112023020584A patent/BR112023020584A2/pt unknown
-
2023
- 2023-11-07 CO CONC2023/0015121A patent/CO2023015121A2/es unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Puck et al. | A rapid method for viable cell titration and clone production with HeLa cells in tissue culture: the use of X-irradiated cells to supply conditioning factors | |
| JP2023052777A5 (https=) | ||
| Wang et al. | Human NK cells maintain licensing status and are subject to killer immunoglobulin-like receptor (KIR) and KIR-ligand inhibition following ex vivo expansion | |
| JP2016509840A5 (https=) | ||
| CN107636150A (zh) | 半静态细胞培养 | |
| PT1956080E (pt) | Uso de il-7 e il-15 para a modificação genética de linfócitos t da memória | |
| CN107002036A (zh) | 用于建立具有编码抗原特异性t细胞受体的基因的多能性干细胞的方法 | |
| JP2024515064A5 (https=) | ||
| CN116004533A (zh) | iNKT细胞的激活扩增方法及其培养基组合 | |
| Harvey et al. | Cell‐cell contact and anatomical compatibility in stromal cell‐mediated HSC support during development | |
| JP2023509388A5 (https=) | ||
| JP2022529741A5 (https=) | ||
| CN114149969B (zh) | 一种选择性扩增同种反应性nk细胞的nk细胞体外培养方法 | |
| Chern et al. | Assignment of the structural genes for the α subunit of hexosaminidase A, mannosephosphate isomerase, and pyruvate kinase to the region q22-qter of human chromosome 15 | |
| Vizcardo et al. | A three-dimensional thymic culture system to generate murine induced pluripotent stem cell-derived tumor antigen-specific thymic emigrants | |
| Smerchansky et al. | Engineered multicellular niches for pluripotent stem cell–derived immunotherapy | |
| JP2025502150A5 (https=) | ||
| CN112553157B (zh) | 一种淋巴细胞的扩增体系及扩增方法 | |
| BACH | Differential function of MHC LD and SD determinants | |
| Nagatake et al. | Lymphoid tissues associated with gastrointestinal (GI) mucosa | |
| Aarden et al. | Limiting dilution analysis of the suppressive effect mediated by alloantigen-primed cells | |
| JPWO2021100585A5 (https=) | ||
| EP3564365B1 (en) | Transdifferentation of b lymphoid cells into t cells | |
| Gorczynski et al. | Altered lymphocyte recognition repertoire during ageing. III. Changes in MHC restriction patterns in parental T lymphocytes and diminution in T suppressor function | |
| Muñoz et al. | Ex vivo expansion and lentiviral transduction of Macaca nemestrina CD4+ T cells |